• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

颗粒蛋白前体突变与临床和神经病理学阿尔茨海默病。

Progranulin mutations in clinical and neuropathological Alzheimer's disease.

机构信息

Taub Institute for Research on Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, New York, USA.

The Gertrude H. Sergievsky Center, College of Physicians and Surgeons, Columbia University, New York, New York, USA.

出版信息

Alzheimers Dement. 2022 Dec;18(12):2458-2467. doi: 10.1002/alz.12567. Epub 2022 Feb 9.

DOI:10.1002/alz.12567
PMID:35258170
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9360185/
Abstract

INTRODUCTION

Progranulin (GRN) mutations occur in frontotemporal lobar degeneration (FTLD) and in Alzheimer's disease (AD), often with TDP-43 pathology.

METHODS

We determined the frequency of rs5848 and rare, pathogenic GRN mutations in two autopsy and one family cohort. We compared Braak stage, β-amyloid load, hyperphosphorylated tau (PHFtau) tangle density and TDP-43 pathology in GRN carriers and non-carriers.

RESULTS

Pathogenic GRN mutations were more frequent in all cohorts compared to the Genome Aggregation Database (gnomAD), but there was no evidence for association with AD. Pathogenic GRN carriers had significantly higher PHFtau tangle density adjusting for age, sex and APOE ε4 genotype. AD patients with rs5848 had higher frequencies of hippocampal sclerosis and TDP-43 deposits. Twenty-two rare, pathogenic GRN variants were observed in the family cohort.

DISCUSSION

GRN mutations in clinical and neuropathological AD increase the burden of tau-related brain pathology but show no specific association with β-amyloid load or AD.

摘要

简介

颗粒体蛋白前体(GRN)突变可发生于额颞叶痴呆(FTLD)和阿尔茨海默病(AD)中,通常伴有 TDP-43 病理学改变。

方法

我们在两个尸检队列和一个家系队列中,测定了 rs5848 及罕见致病性 GRN 突变的频率。我们比较了 GRN 携带者与非携带者的 Braak 分期、β-淀粉样蛋白负荷、磷酸化 tau(PHFtau)缠结密度和 TDP-43 病理学。

结果

与基因组聚集数据库(gnomAD)相比,所有队列中的致病性 GRN 突变频率均较高,但与 AD 无关。在调整年龄、性别和 APOE ε4 基因型后,致病性 GRN 携带者的 PHFtau 缠结密度显著升高。rs5848 的 AD 患者的海马硬化和 TDP-43 沉积物的频率更高。在家系队列中观察到 22 种罕见的致病性 GRN 变体。

讨论

临床和神经病理学 AD 中的 GRN 突变增加了与 tau 相关的脑病理学负担,但与 β-淀粉样蛋白负荷或 AD 无特定关联。

相似文献

1
Progranulin mutations in clinical and neuropathological Alzheimer's disease.颗粒蛋白前体突变与临床和神经病理学阿尔茨海默病。
Alzheimers Dement. 2022 Dec;18(12):2458-2467. doi: 10.1002/alz.12567. Epub 2022 Feb 9.
2
Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion.C9ORF72 六核苷酸重复扩展相关额颞叶变性中的 Tau 病理学。
Acta Neuropathol. 2013 Feb;125(2):289-302. doi: 10.1007/s00401-012-1048-7. Epub 2012 Sep 28.
3
Serum progranulin levels in patients with frontotemporal lobar degeneration and Alzheimer's disease: detection of GRN mutations in a Spanish cohort.血清颗粒蛋白前体水平在额颞叶变性和阿尔茨海默病患者中的变化:在西班牙队列中检测 GRN 突变。
J Alzheimers Dis. 2012;31(3):581-91. doi: 10.3233/JAD-2012-112120.
4
Alzheimer neuropathology without frontotemporal lobar degeneration hallmarks (TAR DNA-binding protein 43 inclusions) in missense progranulin mutation Cys139Arg.伴有错误义突变 Cys139Arg 的颗粒体蛋白前体(TAR DNA 结合蛋白 43 包涵体)但无额颞叶变性特征的阿尔茨海默病神经病理学。
Brain Pathol. 2018 Jan;28(1):72-76. doi: 10.1111/bpa.12480. Epub 2017 Feb 15.
5
Brain progranulin expression in GRN-associated frontotemporal lobar degeneration.脑颗粒蛋白前体在 GRN 相关额颞叶变性中的表达。
Acta Neuropathol. 2010 Jan;119(1):111-22. doi: 10.1007/s00401-009-0576-2. Epub 2009 Aug 2.
6
Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C-->T (Arg493X) mutation: an international initiative.常见的1477C→T(Arg493X)突变患者中与前颗粒蛋白单倍剂量不足相关的表型变异性:一项国际倡议。
Lancet Neurol. 2007 Oct;6(10):857-68. doi: 10.1016/S1474-4422(07)70221-1.
7
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study.携带 GRN 基因突变的额颞叶痴呆患者的疾病风险和发病年龄的潜在遗传修饰因子:一项全基因组关联研究。
Lancet Neurol. 2018 Jun;17(6):548-558. doi: 10.1016/S1474-4422(18)30126-1. Epub 2018 Apr 30.
8
Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration.脑脊液 tau、神经丝和颗粒蛋白在明确的额颞叶变性中的诊断价值。
Alzheimers Res Ther. 2018 Mar 20;10(1):31. doi: 10.1186/s13195-018-0364-0.
9
Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration.与原纤维蛋白相关的额颞叶痴呆的遗传和临床特征
Arch Neurol. 2011 Apr;68(4):488-97. doi: 10.1001/archneurol.2011.53.
10
Expression of TMEM106B, the frontotemporal lobar degeneration-associated protein, in normal and diseased human brain.TMEM106B 蛋白在正常和病变人脑组织中的表达,该蛋白与额颞叶痴呆相关。
Acta Neuropathol Commun. 2013 Jul 11;1:36. doi: 10.1186/2051-5960-1-36.

引用本文的文献

1
PGRN as an emerging regulator of lipid metabolism in neurodegenerative diseases.原纤维蛋白聚糖作为神经退行性疾病中脂质代谢的新兴调节因子。
Commun Biol. 2025 Jun 2;8(1):844. doi: 10.1038/s42003-025-08272-9.
2
LATE-NC Stage 3: a diagnostic rubric to differentiate severe LATE-NC from FTLD-TDP.晚期神经认知障碍3期:一种区分重度晚期神经认知障碍与额颞叶痴呆-4型的诊断标准。
Acta Neuropathol. 2025 Apr 28;149(1):38. doi: 10.1007/s00401-025-02876-5.
3
Biomarker identification for Alzheimer's disease through integration of comprehensive Mendelian randomization and proteomics data.通过整合全面的孟德尔随机化和蛋白质组学数据鉴定阿尔茨海默病的生物标志物
J Transl Med. 2025 Mar 6;23(1):278. doi: 10.1186/s12967-025-06317-5.
4
Understanding recent advances in non-amyloid/non-tau (NANT) biomarkers and therapeutic targets in Alzheimer's disease.了解阿尔茨海默病中非淀粉样蛋白/非tau蛋白(NANT)生物标志物和治疗靶点的最新进展。
Alzheimers Dement (N Y). 2024 Nov 22;10(4):e70014. doi: 10.1002/trc2.70014. eCollection 2024 Oct-Dec.
5
ABCA7-dependent induction of neuropeptide Y is required for synaptic resilience in Alzheimer's disease through BDNF/NGFR signaling.ABCA7 依赖性神经肽 Y 的诱导是通过 BDNF/NGFR 信号在阿尔茨海默病中维持突触可塑性所必需的。
Cell Genom. 2024 Sep 11;4(9):100642. doi: 10.1016/j.xgen.2024.100642. Epub 2024 Aug 30.
6
Characterization of Progranulin Gene Mutations in Portuguese Patients with Frontotemporal Dementia.葡萄牙额颞叶痴呆患者中颗粒蛋白前体基因突变的特征。
Int J Mol Sci. 2023 Dec 29;25(1):511. doi: 10.3390/ijms25010511.
7
Progranulinopathy: A diverse realm of disorders linked to progranulin imbalances.颗粒蛋白前体病:与颗粒蛋白失衡相关的多种疾病领域。
Cytokine Growth Factor Rev. 2024 Apr;76:142-159. doi: 10.1016/j.cytogfr.2023.11.001. Epub 2023 Nov 11.
8
A genome-wide search for pleiotropy in more than 100,000 harmonized longitudinal cognitive domain scores.对超过 100,000 项经协调的纵向认知领域评分进行全基因组范围内的多效性搜索。
Mol Neurodegener. 2023 Jun 22;18(1):40. doi: 10.1186/s13024-023-00633-4.
9
Combined analysis of single-cell and bulk RNA sequencing reveals the expression patterns of circadian rhythm disruption in the immune microenvironment of Alzheimer's disease.单细胞和批量 RNA 测序的联合分析揭示了阿尔茨海默病免疫微环境中生物钟紊乱的表达模式。
Front Immunol. 2023 May 12;14:1182307. doi: 10.3389/fimmu.2023.1182307. eCollection 2023.
10
TDP-43 Proteinopathy and Tauopathy: Do They Have Pathomechanistic Links?TDP-43 蛋白病和 tau 蛋白病:它们有病理发生机制联系吗?
Int J Mol Sci. 2022 Dec 12;23(24):15755. doi: 10.3390/ijms232415755.

本文引用的文献

1
The mutational constraint spectrum quantified from variation in 141,456 humans.从 141456 名人类个体的变异中量化的突变约束谱。
Nature. 2020 May;581(7809):434-443. doi: 10.1038/s41586-020-2308-7. Epub 2020 May 27.
2
Cerebrospinal fluid progranulin is associated with increased cortical thickness in early stages of Alzheimer's disease.脑脊髓液中的颗粒蛋白前体与阿尔茨海默病早期阶段皮质厚度增加有关。
Neurobiol Aging. 2020 Apr;88:61-70. doi: 10.1016/j.neurobiolaging.2019.12.012. Epub 2019 Dec 20.
3
Deep whole-genome sequencing of 3 cancer cell lines on 2 sequencing platforms.对 2 个测序平台上的 3 种癌细胞系进行深度全基因组测序。
Sci Rep. 2019 Dec 13;9(1):19123. doi: 10.1038/s41598-019-55636-3.
4
Microglial Progranulin: Involvement in Alzheimer's Disease and Neurodegenerative Diseases.小胶质细胞颗粒蛋白:在阿尔茨海默病和神经退行性疾病中的作用。
Cells. 2019 Mar 11;8(3):230. doi: 10.3390/cells8030230.
5
Genetic screen in a large series of patients with primary progressive aphasia.在一大系列原发性进行性失语症患者中进行遗传筛查。
Alzheimers Dement. 2019 Apr;15(4):553-560. doi: 10.1016/j.jalz.2018.10.009. Epub 2019 Jan 25.
6
Translating the biology of aging into novel therapeutics for Alzheimer disease.将衰老生物学转化为阿尔茨海默病的新型治疗方法。
Neurology. 2019 Jan 8;92(2):84-93. doi: 10.1212/WNL.0000000000006745. Epub 2018 Dec 7.
7
Recent Advances in Multi-target Anti-Alzheimer Disease Compounds (2013 Up to the Present).近年来多靶点抗老年痴呆化合物的研究进展(2013 年至今)。
Curr Med Chem. 2019;26(30):5684-5710. doi: 10.2174/0929867326666181203124102.
8
CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline.脑脊液中的颗粒蛋白前体在阿尔茨海默病的病程中增加,并与 sTREM2、神经退行性变和认知能力下降相关。
EMBO Mol Med. 2018 Dec;10(12). doi: 10.15252/emmm.201809712.
9
Whole exome sequencing study identifies novel rare and common Alzheimer's-Associated variants involved in immune response and transcriptional regulation.全外显子组测序研究鉴定出新型罕见和常见的与阿尔茨海默病相关的变异,这些变异参与免疫反应和转录调控。
Mol Psychiatry. 2020 Aug;25(8):1859-1875. doi: 10.1038/s41380-018-0112-7. Epub 2018 Aug 14.
10
A multi-omic atlas of the human frontal cortex for aging and Alzheimer's disease research.人类前额叶皮层衰老和阿尔茨海默病研究的多组学图谱
Sci Data. 2018 Aug 7;5:180142. doi: 10.1038/sdata.2018.142.